Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study

Effectiveness and safety of glucagon-like peptide 1 receptor agonists in patients with type 2 diabetes: evidence from a retrospective real-world study

IntroductionGlobal phase III clinical trials have shown superior hypoglycemic efficacy to insulin and other oral hypoglycemic agents. However, there is a scarcity of real-world data comparing different glucagon-like peptide 1 receptor agonist (GLP-1RA) directly. This study aimed to assess the safety...

Full description

Bibliographic Details
Main Authors: Yan Jiang, Han-Sheng Bai, Guo-Xin Liu, Shi-Yi Wang, Li Yin, Zhao-Ting Hou, Chen-Yang Zhao, Guang-Jun Fan
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Frontiers in Endocrinology
Subjects:
GLP-1RA
real-world evidence
type 2 diabetes mellitus
effectiveness
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1347684/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1347684/full

Similar Items